Evidence map›Paper›PMID 24886930›Full record

ArticlePloS one2014

The HIVToolbox 2 web system integrates sequence, structure, function and mutation analysis.

David P Sargeant, Sandeep Deverasetty, Christy L Strong, Izua J Alaniz, Alexandria Bartlett, Nicholas R Brandon, Steven B Brooks, Frederick A Brown, Flaviona Bufi, Monika Chakarova and 21 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. A fourfold pathogen reference ontology suite.Journal of biomedical semantics · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. The Infectious Disease Ontology in the age of COVID-19.Journal of biomedical semantics · 2021
    Article
  6. Article
  7. Minimotifs dysfunction is pervasive in neurodegenerative disorders.Alzheimer's & dementia (New York, N. Y.) · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 2 institutions in 1 country.

David P SargeantSchool of Life Sciences, University of Nevada Las Vegas, Las Vegas, Nevada, United States of America.
Sandeep DeverasettySchool of Life Sciences, University of Nevada Las Vegas, Las Vegas, Nevada, United States of America.
Christy L StrongSchool of Life Sciences, University of Nevada Las Vegas, Las Vegas, Nevada, United States of America.
Izua J AlanizSchool of Life Sciences, University of Nevada Las Vegas, Las Vegas, Nevada, United States of America.
Alexandria BartlettSchool of Life Sciences, University of Nevada Las Vegas, Las Vegas, Nevada, United States of America.
Nicholas R BrandonSchool of Life Sciences, University of Nevada Las Vegas, Las Vegas, Nevada, United States of America.
Steven B BrooksSchool of Life Sciences, University of Nevada Las Vegas, Las Vegas, Nevada, United States of America.
Frederick A BrownSchool of Life Sciences, University of Nevada Las Vegas, Las Vegas, Nevada, United States of America.
Flaviona BufiSchool of Life Sciences, University of Nevada Las Vegas, Las Vegas, Nevada, United States of America.
Monika ChakarovaSchool of Life Sciences, University of Nevada Las Vegas, Las Vegas, Nevada, United States of America.
Roxanne P DavidSchool of Life Sciences, University of Nevada Las Vegas, Las Vegas, Nevada, United States of America.
Karlyn M DobritchSchool of Life Sciences, University of Nevada Las Vegas, Las Vegas, Nevada, United States of America.
Horacio P GuerraSchool of Life Sciences, University of Nevada Las Vegas, Las Vegas, Nevada, United States of America.
Michael W HeddenSchool of Life Sciences, University of Nevada Las Vegas, Las Vegas, Nevada, United States of America.
Rma KumraSchool of Life Sciences, University of Nevada Las Vegas, Las Vegas, Nevada, United States of America.
Kelvy S LevittSchool of Life Sciences, University of Nevada Las Vegas, Las Vegas, Nevada, United States of America.
Kiran R MathewSchool of Life Sciences, University of Nevada Las Vegas, Las Vegas, Nevada, United States of America.
Ray MattiSchool of Life Sciences, University of Nevada Las Vegas, Las Vegas, Nevada, United States of America.
Dorothea Q MazaSchool of Life Sciences, University of Nevada Las Vegas, Las Vegas, Nevada, United States of America.
Sabyasachy MistrySchool of Life Sciences, University of Nevada Las Vegas, Las Vegas, Nevada, United States of America.
Nemanja NovakovicSchool of Life Sciences, University of Nevada Las Vegas, Las Vegas, Nevada, United States of America.
Austin PomerantzSchool of Life Sciences, University of Nevada Las Vegas, Las Vegas, Nevada, United States of America.
Josue PortilloSchool of Life Sciences, University of Nevada Las Vegas, Las Vegas, Nevada, United States of America.
Timothy F RafalskiSchool of Life Sciences, University of Nevada Las Vegas, Las Vegas, Nevada, United States of America.
Viraj R RathnayakeSchool of Life Sciences, University of Nevada Las Vegas, Las Vegas, Nevada, United States of America.
Noura RezapourSchool of Life Sciences, University of Nevada Las Vegas, Las Vegas, Nevada, United States of America.
Sarah SongaoSchool of Life Sciences, University of Nevada Las Vegas, Las Vegas, Nevada, United States of America.
Sean L TuggleSchool of Life Sciences, University of Nevada Las Vegas, Las Vegas, Nevada, United States of America.
Sandy YousifSchool of Life Sciences, University of Nevada Las Vegas, Las Vegas, Nevada, United States of America.
David I DorskyDepartment of Medicine, University of Connecticut Health Center, Farmington, Connecticut, United States of America.
Martin R SchillerSchool of Life Sciences, University of Nevada Las Vegas, Las Vegas, Nevada, United States of America.
University of Nevada, Las Vegas · USUConn Health · US

Funding

UNDERGRADUATE RESEARCH AND TRAININGP20RR016464 · NCRR · UNIVERSITY OF NEVADA RENO · PI REDELMAN, DOUGLAS · 2001 to 2011
$30.3M
Identification of short functional motifs as potential drug targets for HIVR21AI078708 · NIAID · UNIVERSITY OF NEVADA LAS VEGAS · PI SCHILLER, MARTIN R · 2008 to 2009
$368k
CYTOLYTIC MECHANISMS OF NATURAL KILLER CELLSF32AI007870 · NIAID · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI NAGLER, CATHRYN R · 1988 to 1989
–
NCRR NIH HHS P20 RR016464NCRR NIH HHS RR016464NIAID NIH HHS AI07870NIAID NIH HHS AI078708-03S1NIAID NIH HHS R21 AI078708NIGMS NIH HHS GM07689
6 · The paper itself

Abstract

There is enormous interest in studying HIV pathogenesis for improving the treatment of patients with HIV infection. HIV infection has become one of the best-studied systems for understanding how a virus can hijack a cell. To help facilitate discovery, we previously built HIVToolbox, a web system for visual data mining. The original HIVToolbox integrated information for HIV protein sequence, structure, functional sites, and sequence conservation. This web system has been used for almost 40,000 searches. We report improvements to HIVToolbox including new functions and workflows, data updates, and updates for ease of use. HIVToolbox2, is an improvement over HIVToolbox with new functions. HIVToolbox2 has new functionalities focused on HIV pathogenesis including drug-binding sites, drug-resistance mutations, and immune epitopes. The integrated, interactive view enables visual mining to generate hypotheses that are not readily revealed by other approaches. Most HIV proteins form multimers, and there are posttranslational modification and protein-protein interaction sites at many of these multimerization interfaces. Analysis of protease drug binding sites reveals an anatomy of drug resistance with different types of drug-resistance mutations regionally localized on the surface of protease. Some of these drug-resistance mutations have a high prevalence in specific HIV-1 M subtypes. Finally, consolidation of Tat functional sites reveals a hotspot region where there appear to be 30 interactions or posttranslational modifications. A cursory analysis with HIVToolbox2 has helped to identify several global patterns for HIV proteins. An initial analysis with this tool identifies homomultimerization of almost all HIV proteins, functional sites that overlap with multimerization sites, a global drug resistance anatomy for HIV protease, and specific distributions of some DRMs in specific HIV M subtypes. HIVToolbox2 is an open-access web application available at [http://hivtoolbox2.bio-toolkit.com].

Indexed as

MutationSoftwareAmino Acid SequenceAnti-HIV AgentsBinding SitesDatabases, GeneticDNA Mutational AnalysisDrug Resistance, ViralHIVHuman Immunodeficiency Virus ProteinsHumansInternetProtein ConformationProtein MultimerizationProtein Processing, Post-TranslationalSequence Analysis, ProteinAnti-HIV AgentsHuman Immunodeficiency Virus Proteins

Identifiers

PMID24886930
PMCPMC4041786
OpenAlexW2066958539

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.